Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains

Clinical and Experimental Immunology

Volumn 153, Issue 2, 2008, Pages 297-306

  Brando, R J F ^a   Miliwebsky, E ^b   Bentancor, L ^a   Deza, N ^b   Baschkier, A ^b   Ramos, M V ^a   Fernandez G C ^a,c   Meiss, R ^d   Rivas, M ^b   Palermo, M S ^a,c,e  

^a Instituto de Investigationes Hematológicas

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c Instituto de Leucemia Experimental (CONICET)

^d ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^e INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

HUS mouse model; Oral infection; Renal damage; Stx2

Indexed keywords

UREA; VEROTOXIN 2;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM ADHERENCE; BAGG ALBINO MOUSE; CONTROLLED STUDY; DEATH; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI O157; FEMALE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HISTOPATHOLOGY; IMMUNE RESPONSE; INOCULATION; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC DISEASE; THROMBOCYTOPENIA; UREA BLOOD LEVEL; WEANING;

AGE FACTORS; ANIMALS; DIARRHEA; FEMALE; FOOD POISONING; HEMOLYTIC-UREMIC SYNDROME; INTESTINES; KIDNEY; MALNUTRITION; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; SURVIVAL RATE; WEANING;

EID: 47249141725     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03698.x     Document Type: Article

References (44)

1. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998 11:142 201.
2. Riley LW, Remis RS, Helgerson SD et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983 308:681 5.
3. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991 13:60 98.
4. Gal-Mor O, Finlay BB. Pathogenicity islands: a molecular toolbox for bacterial virulence. Cell Microbiol 2006 8:1707 19.
5. Garmendia J, Frankel G, Crepin VF. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Review. Infect Immun 2005 73:2573 85.
6. Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 1998 11:450 9.
7. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Review. Lancet 2005 365:1073 86.
8. Acheson DW, Moore R, De Breucker S et al. Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect Immun 1996 64:3294 300.
9. Ochoa TJ, Cleary TG. Epidemiology and spectrum of disease of Escherichia coli O157. Review. Curr Opin Infect Dis 2003 16:259 63.
10. Ritchie JM, Thorpe CM, Rogers AB, Waldor MK. Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun 2003 71:7129 39.
11. Fernandez GC, Lopez MF, Gomez SA et al. Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia. Clin Exp Immunol 2006 146:76 84.
12. Lindgren SW, Melton AR, O'Brien AD. Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model. Infect Immun 1993 61:3832 42.
13. Wadolkowski EA, Burris JA, O'Brien AD. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 1990 58:2438 45.
14. Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O'Brien AD. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 1990 58:3959 65.
15. Grif K, Dierich MP, Karch H, Allerberger F. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis 1998 17:761 66.
16. Domingo S, Diaz R, Gamazo C. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice. FEMS Immunol Med Microbiol 1995 12:91 5.
17. Kita E, Yunou Y, Kurioka T et al. Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun 2000 68:1207 14.
18. Kurioka T, Yunou Y, Kita E. Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun 1998 66:1726 34.
19. Fujii J, Kita T, Yoshida S et al. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H7 in mitomycin-treated mice. Infect Immun 1994 62:3447 53.
20. Molyneux G, Gibson FM, Gordon-Smith EC et al. The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse. Int J Exp Pathol 2005 86:415 30.
21. Nagano K, Taguchi K, Hara T, Yokoyama S, Kawada K, Mori H. Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice. Microbiol Immunol 2003 47:125 32.
22. Isogai E, Isogai H, Kimura K et al. Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Infect Immun 1998 66:197 202.
23. Sperandio V, Torres AG, Giron JA, Kaper JB. Quorum sensing is a global regulatory mechanism in enterohemorrhagic Escherichia coli O157:H7. J Bacteriol 2001 183:5187 97.
24. Dean EA, Whipp SC, Moon HW. Age-specific colonization of porcine intestinal epithelium by 987P-piliated enterotoxigenic Escherichia coli. Infect Immun 1989 57:82 7.
25. Fernandez MI, Thuizat A, Pedron T, Neutra M, Phalipon A, Sansonetti PJ. A newborn mouse model for the study of intestinal pathogenesis of shigellosis. Cell Microbiol 2003 5:481 91.
26. Ohara T, Kojio S, Taneike I et al. Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response. Antimicrob Agents Chemother 2002 46:3478 83.
27. O'Brien AD, Lively TA, Chen ME, Rothman SW, Formal SB. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (Shiga) like cytotoxin. Lancet 1983 1:702.
28. Karmali MA, Mascarenhas M, Shen S et al. Association of genomic Oisland 122 of Escherichia coli EDL933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 2003 41:4930 40.
29. Rivas M, Miliwebsky E, Chinen I et al. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathogens Dis 2006 3:88 96.
30. Leotta GA, Chinen I, Epszteyn S et al. Validation of a multiplex PCR for detection of Shiga toxin-producing Escherichia coli. Rev Argent Microbiol 2005 37:1 10.
31. Ziebell KA, Read SC, Johnson RP, Gyles CL. Evaluation of PCR and PCR RFLP protocols for identifying Shiga toxins. Res Microbiol 2002 153:289 300.
32. Paton AW, Paton JC. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J Clin Microbiol 1998 36:598 602.
33. Ørskov F, Ørskov I. Serotyping of Escherichia coli. In:Bergan T, ed. Methods in microbiology, vol. 14. London:Academic Press, 1984:43 112.
34. Aiquel F. Heces. Manual de Análisis Clínicos (Faeces. Manual of Clinical Studies), 4th edn. Buenos Aires:Panamericana, 1977:473.
35. Conlan JW, Perry MB. Susceptibility of three strains of conventional adult mice to intestinal colonization by an isolate of Escherichia coli O157:H7. Can J Microbiol 1998 44:800 5.
36. Conlan JW, Bardy SL, KuoLee R, Webb A, Perry MB. Ability of Escherichia coli O157:H7 isolates to colonize the intestinal tract of conventional adult CD1 mice is transient. Can J Microbiol 2001 47:91 5.
37. Diaz RL, Hoang L, Wang J et al. Maternal adaptive immunity influences the intestinal microflora of suckling mice. J Nutr 2004 134:2359 64.
38. Nagano K, Sugisaki T, Taguchi K, Hara T, Naiki M, Mori H. A murine model of enterohemorrhagic Escherichia coli O157:H7 infection to assess immunopotentiating activity of drugs on mucosal immunity: effect of drugs. J Pharmacol Sci 2003 91:219 28.
39. Uren TK, Johansen FE, Wijburg OL, Koentgen F, Brandtzaeg P, Strugnell RA. Role of the polymeric Ig receptor in mucosal B cell homeostasis. J Immunol 2003 170:2531 9.
40. Cebra JJ, Bos NA, Cebra ER et al. Development of components of the mucosal immune system in SCID recipient mice. Adv Exp Med Biol 1994 355:255 9.
41. Mundy R, Girard F, FitzGerald AJ, Frankel G. Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. FEMS Microbiol Lett 2006 265:126 32.
42. Sjogren R, Neill R, Rachmilewitz D et al. Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. Gastroenterology 1994 106:540 3.
43. Dean-Nystrom EA, Bosworth BT, Cray WC, Moon HV. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect Immun 1997 65:1842 8.
44. Dran GI, Fernandez GC, Rubel CJ et al. Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome. Kidney Int 2002 62:1338 48.